Peptoid analogues of anoplin show antibacterial Activity

Protein and Peptide Letters

Volumn 16, Issue 9, 2009, Pages 1006-1011

  Meinike, K ^a,b   Hansen, P R ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b STATENS SERUM INSTITUT   (Denmark)

Author keywords

Anoplin; Antibacterial agents; Peptoid; Solid phase synthesis

Indexed keywords

ANOPLIN; ANTIINFECTIVE AGENT; ANTIMICROBIAL CATIONIC PEPTIDE; PEPTOID; WASP VENOM;

AMINO ACID SEQUENCE; ARTICLE; CHEMISTRY; CIRCULAR DICHROISM; DRUG EFFECT; ESCHERICHIA COLI; HEMOLYSIS; HUMAN; MICROBIOLOGICAL EXAMINATION; STAPHYLOCOCCUS AUREUS; SYNTHESIS;

AMINO ACID SEQUENCE; ANTI-BACTERIAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; CIRCULAR DICHROISM; ESCHERICHIA COLI; HEMOLYSIS; HUMANS; MICROBIAL SENSITIVITY TESTS; PEPTOIDS; STAPHYLOCOCCUS AUREUS; WASP VENOMS;

ESCHERICHIA COLI;

EID: 69549091510     PISSN: 09298665     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986609789055421     Document Type: Article

References (28)

1. Lohner, K.; Staudegger, E.In Development of novel antimicrobial agents: emerging strategies, Lohner Ed.; Horizon Scientific Press: Wymondham, 2001; pp.1-15.
2. Boman, H.G.Innate immunity and the normal microflora.Immunol.Rev., 2000, 173(1), 5-16.
3. Nicolas, P.; Mor, A.Peptides as weapons against microorganisms in the chemical defense system of vertebrates.Annu.Rev.Microbiol., 1995, 49, 277-304.
4. Zasloff, M.Antimicrobial peptides of multicellular organisms.Nature, 2002, 415(6870), 389-395.
5. Hoskin, D.W.; Ramamoorthy, A.Studies on anticancer activities of antimicrobial peptides.Biochim.Biophys.Acta, 2008, 1778 (2), 357-75.
6. Yeaman, M.R.; Yount, N.Y.Mechanisms of Antimicrobial Peptide Action and Resistance.Pharmacol Rev., 2003, 55(1), 27-55.
7. Mookherjee, N.; Hancock, R.E.W.Cationic host defence peptides: innate immune regulatory peptides as a novel approach for treating infections.Cell Mol.Life Sci., 2007, 64(7-8), 922-33.
8. Brogden, K.A.Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat.Rev.Microbiol., 2005, 3(3), 238-250.
9. Hancock, R.E.; Hale, J.D.Alternative mechanisms of action of cationic antimicrobial peptides on bacteria.Expert Rev.Anti.Infect.Ther., 2007, 5(6), 951-959.
10. Zanetti, M.Cathelicidins, multifunctional peptides of the innate immunity.J.Leukocyte Biol., 2004, 75 (1), 39-48
11. Wong, J.W.; Xia, L.; Ng, T.B.A review of defensins of diverse origins.Curr.Protein Pept.Sci., 2007, 8(5), 446-59.
12. Wehkamp, J.; Schmid, M.; Fellermann, K.; Eduard, F.; Stange, E.F.Defensin deficiency, intestinal microbes, and the clinical phenotypes of Crohn's disease.J.Leukocyte Biol., 2005, 77(1), 460-465.
13. Wang, G.S.Tool Developments for Structure-Function Studies of Host Defense Peptides.Protein Pept.Lett., 2007, 14(1), 57-69.
14. Miller, S.M.; Simon, R.J.; Ng, S.; Zuckermann, R.N.; Kerr, J.M.; Moos, W.H.Proteolytic studies of homologous peptide and Nsubstituted glycine.Bioorg.Med.Chem.Lett., 1994, 4(22), 2657- 62.
15. Zuckermann,R.N.; Kerr, J.M.; Kent, S.B.H.; Moos, W.H.Efficient method for the preparation of peptoids (oligo(N-substituted glycines)) by submonomer solid-phase synthesis.J.Am.Chem.Soc., 1992, 114(26),10646-10648.
16. Ryge, T.S.; Hansen, P.R.Lysine-Peptoid Hybrids with antibacterial properties J.Peptide Sci., 2005, 11(11), 727-734.
17. Goodson, B.; Ehrhardt, A.; Ng, S.; Nuss, J.; Johnson, K.; Giedlin, M.; Yamamoto, R.; Moos, W.H.; Krebber, A.; Ladner, M.; Giacona, M.B.; Vitt, C.; Winter, J.Characterization of Novel Antimicrobial Peptoids.Antimicrob.Agents Chemother., 1999, 43(6), 1429-1434.
18. Ryge, T.S.; Frimodt-Møller, N.; Hansen, P.R.Antimicrobial activities of Lysine-Peptoid Hybrids against Clinically Relevant Bacteria and Fungi.Chemotherapy, 2008, 54(2), 152-156.
19. Konno, K.; Hisada, M.; Fontana, R.; Lorenzi, C.; Naoki, H.; Itagaki, Y.; Miwa, A.; Kawai, N.; Nakata, Y.; Yasuhara, T.; Ruggiero Neto, J.; de Azevedo, W.; Palma, M.; Nakajima, T.Anoplin, a novel antimicrobial peptide from the venom of the solitary wasp Anoplius samariensis.Biochim.Biophys.Acta, 2001, 1550(1), 70- 80.
20. Ifrah, D.; Doisy, X.; Ryge, T.S.; Hansen, P.R.Structure activity study of anoplin.J.Peptide Sci., 2005, 11(2),113-21.
21. Chan, W.C.; White, P.D.In: Fmoc Solid-phase peptide synthesis.Oxford Univ.Press; Oxford, 2000.
22. Nielsen, S.L.; Frimodt-Møller, N.; Kragelund B.B.; Hansen, P.R.Structure-Activity study of the antibacterial peptide Fallaxin.Protein Sci., 2007, 16(9), 1969-1976.
23. Mshana, R.N.; Tadesse, G.; Abate, G.; Miorner, H.Use of 3-(4,5- Dimethylthiazol-2-yl)-2,5-Diphenyl Tetrazolium Bromide for Rapid Detection of Rifampin-Resistant Mycobacterium tuberculosis.J.Clin.Microbiol., 1998, 36(5), 1214-1219.
24. McLean, L.R.; Hagaman, K.A.; Owen, T.J.; Krstenansky, J.L.Minimal peptide length for interaction of amphipathic alpha-helical peptides with phosphatidylcholine liposomes.Biochemistry, 1991, 30(1), 31-3
25. Di Nardo, A.; Yamasaki, K.; Dorschner, R.A.; Yuping L.Y.; Gallo, R.L.Mast cell cathelicidin antimicrobial peptide prevents invasive group A Streptococcus infection of the skin.J.Immunol., 2008, 180(11), 7565-7573.
26. Vallon-Eberhard, A.; Makovitzki, A.; Beauvais, A.; Latgé, J.-P.; Jung, S.; Shai ,Y.Efficient Clearance of Aspergillus Fumigatus By an Ultrashort Anti-Microbial Lipopeptide Palmitoyl-Lys-Ala-dAla- Lys In Murine Lungs Antimicrob.Agents Chemother., 2008, 52(9), 3118-3126.
27. Cabrera, M.P.D.S.; Arcisio-Miranda, M.; Costa, S.T.B.; Konno, K.; Ruggiero, J.R.; Procopioa, J.; Neto, J.R.Study of the mechanism of action of anoplin, a helical antimicrobial decapeptide with ion channel-like activity, and the role of the amidated C-terminus J.Peptide Sci., 2008, 14 (6), 661-669.
28. Dathe, M.; Nikolenko, H.; Klose, J.; Bienert, M.Cyclization increases the antimicrobial activity and selectivity of arginine- and tryptophan-containing hexapeptides.Biochemistry, 2004, 43(28), 9140-50. (Pubitemid 38924447)